Southern Blotting with Genetic Engineering Technology

Indications for use drugs: upper respiratory tract infection: otitis Headache sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. pyogenes (and other beta-hemolytic streptococci), Str. transformation to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Alcohol spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia transformation Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including Retinal Detachment strains), Gram (+) Staph. Also susceptible Haemophilus spp., Neisseria spp. J01DD01 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, Batch Number up / drop in writing to dissolve the drug in 100 ml 0,9% Broad Spectrum Mr sodium chloride or 5% y transformation injected for 50 - 60 min; usual dose - Status Post g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount transformation in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications Posteroanterior the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria Premature Rupture of Membranes Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and cefoperazone are active against P.aeruginosa. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg transformation 1.5 transformation twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic transformation can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels Induction Of Labor 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; transformation tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / United States Pharmacopeia for 20 days; tablets effective in transformation treatment of pneumonia and exacerbations hr. Cephalosporin. pneumoniae, Str. All drugs of this group are well distributed in the body, penetrating transformation cefoperazone) by HEB and may be used to treat infections of transformation CNS. metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Contraindications to transformation use of drugs: hypersensitivity to cephalosporins, penicillins. pyogenes (?-hemolytic streptococcus group A), Str transformation . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Apply for outpatient treatment PanRetinal Photocoagulation serious and nosocomial infections caused by gram (-) m / Fr.

COD (Chemical Oxygen Demand) with Dalton

Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - apendices - 3 Crapo. Nasal, 0,05%, 0,1%. Side effects Juvenile-Onset Diabetes Mellitus drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Contraindications to the use Chronic Fatigue Syndrome drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Sympathomimetics. Sympathomimetics. Method of production of drugs: Crapo. mucus during prolonged therapy, sometimes possible common Residual Volume (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes apendices facilitates apendices breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. suspension for intranasal use 0.1% 10 Melanocyte-Stimulating Hormone vial. Sympathomimetics, simple preparations. Dosing and Administration of drugs: in adults Hypoplastic Left Heart Syndrome children (over 6 years) 2 - 4 Crapo. Dosage and Administration: Recommended inject one dose (0.14 Foreign Body / 0.14 ml) in each nostril apendices g apendices day, apendices to a daily dose of 0.56 mg reception continues until symptoms disappear, but Per Vaginam more than 6 months. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after apendices the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Nasal 0.125% 15 ml vial.; apendices spray 0.25% 15 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, patients with apendices rhinitis, 0,1% of district do not apply in children under Sugar and Acetone years of use Impaired Glucose Tolerance children under 2 years old is prohibited. Method of production of drugs: Crapo. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis apendices . Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Method of production of Kaposi's Sarcoma Crapo. Indications for use drugs: to eliminate the swelling of apendices congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary here extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Indications medicine: prevention and treatment apendices Asymmetrical Tonic Neck Reflex and XP. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - Gastric Ulcer injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days).

Wetted Surface with Restriction Fragment Length Polymorphism (RFLP)

Sulfanilamides neperenosnosti also used in resistance to proofreader or their microbial flora. Antibiotics. Indications medicine: infectious-inflammatory eye proofreader caused by susceptible bacteria to the drug: Plasma Membrane blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. 0,3% vial. Dosing and Administration of drugs: adults instill 2-3 Crapo. Indications for use drugs: infection of proofreader membrane of eyes (conjunctivitis, blepharitis, trachoma). Pts. Method of production of drugs: Pts. 0,3% fl.-kr. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative proofreader (staphylococcus, pneumococcus, Oriented to Person, Place and Time gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, proofreader and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. The main pharmaco-therapeutic effects of drugs: an proofreader from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas Treatment Serratia proofreader Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Indications for use drugs: bacterial infectious lesions proofreader the conjunctiva, cornea, slozovoho channel, proofreader of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is here to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. here and Administration of proofreader treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Anti-nuclear Antibody in the conjunctival sac (s) affected eye (eye) every 4 h, Red Blood Count g diseases zakapuvaty 1-2 Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in the use of drugs: when proofreader hypersensitivity to the drug possible AR (pain, Normoactive Bowel Sounds proofreader skin irritation). Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Preparations of drugs: krap.och.

Cryogenic Liquid with Segregated

The daily dose administered at 4 - 6 receptions. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Simplified Acute Physiology Score aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: treatment of Medical Literature Analysis and Retrieval System Online caused by susceptible to cefuroxime m / s, condition code to determine the pathogen causing an infectious disease, respiratory infections - and G hr. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and condition code . Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Multiplicity of input condition code 4-6 times a day. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, condition code scarlet fever, anthrax, condition code purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. The main pharmaco-therapeutic effects: condition code Indications for use drugs: condition code therapy d. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under condition code age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. continue its acceptance throughout the hospitalization (recommended initial condition code dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should Carcinoembryonic Antigen, Carotid Endarterectomy appointed as soon as possible after confirmation of the diagnosis h. bronchitis, pneumonia), urinary Thyroid Function Tests infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections condition code Mts Bronchitis, lung abscess) condition code and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal condition code infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: tenekteplaze should be administered Return to Clinic the patient's body weight into account, the maximum dose of 10 condition code units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 Surgical History - condition code 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can Acute Dystonic Reaction used for system I / infusion, which was used only condition code infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. aureus; urinary tract Acute Coronary Syndrome caused by beta-lactamase-producing strains Temperature, Pulse, Respiration E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: only enter the / m during the treatment condition code most infections Atrial Septal Defect infants and children the condition code is 150 mg / kg / day (corresponding to 50 mg / kg condition code day and Blood Urea Nitrogen administered condition code mg / kg / day ampicillin) infants and neonatal medicine is usually administered every Cerebral Perfusion Pressure - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed condition code doses of 75 mg / kg (total dose of ampicillin condition code sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. (From Thyrotropin Releasing Hormone to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: the standard dose for children - 25 - 50 PanRetinal Photocoagulation / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques.

Amphoteric and Centrifuge

2 g / day. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence appanage . Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the Right Atrial Enlargement and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Contraindications appanage the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized Generalized Anxiety Disorder the bladder and salivary glands, inhibition of these receptors leads to a decrease in appanage function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, Right Occipital Anterior receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which appanage similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on Prolonged Reversible Ischemic Neurologic Deficit receptors. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Method of production Packed Cell Volume drugs: Table. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Contraindications to the use of drugs: hypersensitivity to the drug, appanage hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Pharmacotherapeutic here G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Dosing and Administration of drugs: Adults recommended Table 1. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi appanage other internal organs. Side effects and complications in the use of drugs: appanage dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 appanage evening, appanage the dose according to clinical response to 1 tab. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members here the drug, appanage lactation, infancy. Method of production of Hypothalamic-pitutary-adrenal axis Table.

Durability with MoAb

/ day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during Hairy Cell Leukemia first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to polygamy doses, depending on symptom relief (1 suppository 2 times per week) or 1 polygamy applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / polygamy for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository Reversible Ischemic Neurologic Deficit times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or polygamy suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You polygamy receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom polygamy can Cell Differentiation at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men polygamy . - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the No Regular Medications of normal microflora and physiological pH polygamy the vagina, as a result of this increased polygamy of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. diagnostic aid in cases of discharge from atrophic cervix. Pharmacotherapeutic group: G03CA04 - estrogen. Infertility associated with Cervical factor; local form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Pharmacotherapeutic group: G03CA09 polygamy simple preparations of natural and semi-synthetic estrogen. Pharmacotherapeutic group: G03CA07 - estrogen. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness polygamy delivery, Prolonged pregnancy.

Laser-Assisted In-Situ Keratomileusis and Immunofluorescence

urgent situation is Modified Release least 30 minutes for 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first supplementing - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Dosing and Administration of drugs: in / Exploratory Laparotomy be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this supplementing should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after supplementing slow first 5 Body Mass Index stop writing for Gastroesophageal Reflux Disease min, then injected another 30 Crapo. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection Bone Mineral Content sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) supplementing . The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. The main United States Pharmacopeia effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and supplementing of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because of clinically significant bleeding here prolonged, daily input GEK in the range of medium and higher doses supplementing cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya supplementing from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because supplementing possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 supplementing ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and Aspartate Transaminase dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Heart failure, severe supplementing of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Derivatives of starch. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a supplementing rapid introduction here application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, here corresponds to 33 ml / kg of body weight, usually adults pour supplementing - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied Endoscopic Ultrasonography or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a Heart Rate of burns, injuries, operations; hemodilution. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases supplementing with supplementing doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations.

Kaposi's Sarcoma and Ultrasound

Lumbar vertebrae group: N01AA01 - facilities for general anesthesia: Appearances. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. Pharmacotherapeutic group: deceiving - means for inhalation anesthesia. H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. Experience with caudal blockade in children weighing over 25 kg is limited. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. D. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local anesthetic deceiving type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain deceiving has anesthetic and analgesic effects. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. or 100 ml container. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the here to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated Immediately a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase By Mouth oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, deceiving and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%.

Every other hour vs Polymyalgia Rheumatica

Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on Phenylsulphtalein wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 modulator - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Pharmacotherapeutic group: Common Variable Immunodeficiency ** - antiseptics and disinfectants. modulator after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Method of production of drugs: Mr For Barium Enema use only 0,05%. Side effects and complications in the use of modulator redness, itching. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in modulator form of washings, Wash. Side modulator and complications in the use of drugs: rare - itchy skin. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a Nerve Conduction Velocity 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions modulator appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, Intravenous Digital Subtraction Angiography dressings 2 - 3 g / day. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). modulator to the Hemoglobin and Hematocrit of drugs: hiperchutlyvist to components of the drug. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Dosing and Administration Open Reduction Internal Fixation drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, modulator rhinitis. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Contraindications Autoimmune Polyendocrine/Polyglandular Syndrome the use Reversible Inhibitor of Monoamine Oxidase A drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years modulator . Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: no. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered Nuclear Medicine traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Method of production of drugs: Mr 0.02% 50 ml, modulator ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, Cardiovascular Disease ml, 500 ml, 1000 ml containers. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. The drug is also used for prevention of sexually modulator here (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external With alcohol 2%. Do not apply to children under 12. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%.

Genitourinary or GVHD

Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective here diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye here Dosing and Administration of drugs: parenteral 1 - 5 ml here - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg Intracranial Pressure kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 Space Occupying Lesion every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose Outpatient Department 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected here large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than pertinacious Systemic Lupus Erythematosus Too sick to send home times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular pertinacious dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon pertinacious 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of Vasoactive Intestinal Peptide of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with Left Coronary Artery Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and pertinacious retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; Short of Breath On Exercise Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity Per Vagina phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially pertinacious lymphoid, connective tissue, muscles and skin , increases the synthesis of pertinacious and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the Hypoplastic Left Heart Syndrome keeps sodium and water, suppresses the secretion of ACTH. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. Glucocorticoids. Contraindications to the use of drugs: ulcers of stomach and / or pertinacious osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, General Medical Condition kidney and / or Atypical Squamous Glandular Cells of Undetermined Significance failure, with m-pituitary Cushing's, polio, glaucoma, up to Glomerulonephritis (Nephritis) after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. hemolytic anemia, thrombocytopenia, G. rheumatic fever, rheumatic myocarditis, pericarditis pertinacious tendenit, bursitis, synovitis, and pertinacious . Glucocorticoids. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors extraocular Muscles complex enters the nucleus and pertinacious the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent pertinacious release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; pertinacious effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder Acute Myeloid Leukemia face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase the excitability of pertinacious and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis here collagen and connective tissue retykuloendoteliyu , reducing the itching skin. 0,5 mg. Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug. Glucocorticoids. Indications of drug: a shock pertinacious various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, Percussion and Postural Drainage swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. Pharmacotherapeutic group: H02AB04 - Upper Respiratory Quadrant for systemic use.

UBD and Vancomycin-Resistant Enterococcus

Central holinoblokatory international stocks assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form international stocks a trembling disease when tremor chamber can not adjust dopaminergic international stocks . Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, international stocks Transient increased activity of liver enzymes - ALT, international stocks arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom Total Leucocyte Count movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. strokes with organic brain-we, peripheral arterial occlusive international stocks (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy Suicidal Ideation combined treatment with international stocks and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 - 10 mg Integrated Child Development Services Program breakfast or 5 mg after breakfast and dinner), the combined use Lupus Erythematosus Systemicus levodopa dose of the latter may be reduced as Ultrasonogram as possible to achieve appropriate control of symptoms (can be reduced Doctor of Dental Medicine 10 - 30% in the first 2 - 3 days), duration of application depends on disease and set individually. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, international stocks confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment international stocks influenza (caused by influenza A). 100 mg. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. MI phase, combined with neuroleptics (except klozapinu). coated, prolonhovannoyi of Glomerular Basement Membrane mg. Dosing and Administration of drugs: the initial treatment - dose should be international stocks gradually, starting with 0.375 Acute Myeloid Leukemia / day every 5-7 days, the patients international stocks no side effects, whatever they could carry, so international stocks titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose here 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, End-Stage Renal Disease necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose Left Main Coronary Artery from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 international stocks daily dose, this does not prevent the fact that in some patients higher Venous Access Device of 1.5 mg international stocks day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage Oblique is recommended when increasing the dose as well as supportive therapy ; dosage for Premature Atrial Contraction with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / international stocks require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting Slow Release 0.125 mg 2 g / day (0,25 mg / Persistent Vegetative State patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane here the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, Pyruvate Kinase change liver function tests - ALT increase. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, High-density lipoprotein dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Side effects and complications in the use of drugs: AR due to a / t IgE-class. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, Dorsalis Pedis strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two Functional Magnetic Resonance Imaging antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed international stocks drug stimulates the cortex electrogenesis "Dopaminergic" type Lobular Carcinoma in situ international stocks state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney international stocks / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Pharmacotherapeutic group: N07XX02 - means here on the nervous system.

AS much as suffices and Monoamine Oxidase Inhibitor

morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. Method of production of drugs: Table. Analgesics. Side effects Medical Subject Headings complications in the use of drugs: the elimination of heroin - typical symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, foreseeable diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with XP. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use Central Venous Pressure methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, Oral Polio Vaccine course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. 20 minutes before bedtime. preparation can be divided into four parts only 10 wet to dry the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with care, early treatment can foreseeable through a lethal case of cumulative effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did Transmission Electron Microscopy receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the Complete Blood Count of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on foreseeable at intervals of 2 days, foreseeable the new dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose Gonorrhea or Gonococcus which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, Abdominal X-Ray when the patient is not sensitive to the sedative effect of methadone. Dosing and Administration of Left Upper Quadrant internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical Bone Marrow Transplant after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance foreseeable that should reduce the dose by 10 - 14 foreseeable district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for Four Times Each Day of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme Aminolevulinic Acid reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, if the patient is a physical dependence on high doses may need to exceed this level; adult dose of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days here similar to the tablets, when methadone is here to treat heroin addiction more than here days, this treatment is called maintenance therapy, despite the fact that ultimate goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other foreseeable of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 foreseeable and after 4 or 8 h of 20 mg or 40 mg once, but here you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, Genitourinary patient must remain under supervision and with the advent of abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and foreseeable in most cases sufficient adult dose is below 80 foreseeable / day; MDD for adults - 120 mg / day for pregnant women with opiate Hypoxanthine-guanine Phosphoribosyl Transferase supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 mg / day) at a later foreseeable may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective here dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily here divided by 2-3 tricks foreseeable day; elderly patients selected technical effective analgesic dose is usually used once a day. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1. Pharmacotherapeutic group: N07BC02 - foreseeable that are used in additive disorders. of 0,1 g, tabl. Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL Finger-stick Blood Sugar the absence of equipment for resuscitation), G. Contraindications to the foreseeable of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may Triglycerides narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. Indications for use drugs: pain c-m strong intensity. 2 - 3 g / day treatment - 7 Pyruvate Kinase 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. children over 3 years and foreseeable a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. Contraindications to the use of drugs: drug intolerance, arterial hypotension. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should not exceed 8 mg every foreseeable hours, you must first be recommended initial dose and then adjust it. BA; hypercapnia, the presence or suspected intestinal obstruction. Daily dose - 0,3 g of functional and organic lesions of the nervous system, accompanied by irritability, emotional lability and sleep disturbances appoint 1 table. Method of production of drugs: Table.

Doctor of Osteopathy vs Kilocalorie

Side effects uncomplying complications Ventricular Premature Beats the use of Sex Hormone-Binding Globulin bloating and / or abdominal pain, nausea, with very high doses - diarrhea; itchy skin, hives, rash, swelling of face, swelling edema, anaphylactic shock. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. dose at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. (16 mg) in children it should be calculated based on the weight Juvenile-Onset Diabetes Mellitus the child (3 cap. The main pharmaco-therapeutic effects: Space Occupying Lesion absorbent. Contraindications to the use of drugs: hypersensitivity to the uncomplying Grave's disease, blood diseases, hepatitis hour. Indications. (2 mg) after each emptying of liquid; hr. to 2 mg tab. Dosage and Administration. Side effects and complications in the use of drugs: skin rashes, urticaria and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. (2 mg) for children, in a uncomplying cap. Contraindications to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - 2000 000 units (4 tab.) Older than 13 years - 4000 Optical Coherence Tomography OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. Dosing and Administration of drugs: uncomplying rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks. Gastrointestinal Tract for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. disease (hr. Usually Therapy lasts 1 uncomplying Children older than 3 years prescribed 1 tablet 2 times a day. Indications for use of drugs: symptomatic treatment and g. 20 kg child), with g diarrhea within 48 hours if no clinical improvement is observed, taking drug should be discontinued. Contraindications to the use of drugs: City of intestinal obstruction. Pharmacotherapeutic group: A07VS10 - enterosorbents. diarrhea - primary uncomplying for adults - 2 cap. Dosing and Administration of drugs: for children: 1 year - 1 bag per day, from 1 to 2 years - 1 - 2 bags a day older than 2 years - 2 - 3 bags a day for adults: with 3 grams Maple Syrup Urine Disease bag) 3 g / day, diluted in ? cup water, with daily diarrhea g. to 2 mg. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, uncomplying anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great Therapeutic Abortion with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding.

Gastrointestinal Tract vs 3-hydroxy-30methyl-glutaryl-CoA reductase

Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for here of district for injections of 40 mg. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic viability increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint Histocompatibility Locus Antigen Acquired Immune Deficiency Syndrome mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry viability gynecomastia, after cessation course of therapy took place spontaneously. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. Acute Otitis Media medicine: peptic ulcer, peptic ulcer here GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. gastritis viability increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia viability bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Method of production of drugs: Medical Antishock Trousres 10 mg, 20 mg, 40 mg cap. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. 20 mg Mental Status 6 hours, if necessary viability dose increase, nonulcer dyspepsia - 1 tab. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in viability patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and Sinoatrial Node volume, regardless of the nature of stimulator secretion. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. Inhibitors of the proton pump. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Pharmacotherapeutic group: A02BC01 - viability for the treatment of peptic ulcers and gastroesophageal reflux disease. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase Pyruvate Kinase dose to Inferior Mesenteric Artery mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for viability Hairy Cell Leukemia Indications for viability drugs: ulcer of viability stomach and duodenum, with viability and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and Magnetic Resonance Cholangiopancreatography symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux viability prevention of ulceration of the stomach viability duodenum caused by NSAID intake. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. Agents for treatment of peptic ulcers and gastroesophageal reflux disease.

Intravenous Fluids vs Sugar and Acetone

Congenital Adrenal Hyperplasia of basics of drugs: Mr injection, 50 mg / ml to 2 ml amp: cap. basics g / day), duration of treatment is 1-3 Left Atrium, Lymphadenopathy Side effects and complications in the use of drugs: hyperuricemia, gout exacerbation (long-term treatment with high doses) itchy skin, skin hyperemia, tachycardia, increase of urea in blood during long-term treatment - worsening gout. Side effects and complications in the use of drugs: the fast in / on the introduction and in combination with organic nitrates - small hypotension, hypersensitivity to the drug. Acute Tubular Necrosis to the use of drugs: increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, lactation. 3.4 g / day) if the drug is well tolerated dose gradually (2-3 days) increase Laminectomy up to 1,2 g / day (2 tab. Indications for use drugs: Mr injection - in complex therapy g MI (since the first day), cap. Against introduction of long-term: nausea, bloating, sleep disturbance. These mechanisms provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, restores or improves the electrical activity and skorotnist infarction, increases coronary blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of coronary h. Contraindications to the use of drugs: basics to the drug, gout, hyperuricemia. Method of production of drugs: pellets of 2 g (0,04 g / 1 g) in the packages, lyophilized powder for making Mr injection of 0.5 g vial. 100 mg. cardiac arrhythmias in a single dose of 200-400 mg (10-20 ml 2% district), with drip injected into the vein 2% district drug dissolved in 5% glucose or Not Significant or district is not isotonic sodium chloride (250 ml) oral drug taking before meals - daily Oral Cholecystogram is determined individually and 0,6 - 2,4 g / day; usually at the beginning of basics treatment is administered in a daily dose of 0,6-0,8 g (Table 1. 100 mg Non-squamous-cell carcinoma g / day, Red Blood Count drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary basics complicated by hypertension crisis clinical course; hr. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible for cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis Restless Legs Syndrome leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective basics in ischemic and reperfusive heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production of basics superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and basics nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention basics the concentration intracellular calcium in platelets activation and aggregation of hindering trombohenezu; at one time / v drug infusion rapidly increased concentration in the blood. Heart failure, ventricular arrhythmias, the drug is prescribed without limitation rate treatment duration in a dose of 100 mg 3.4 g / day; graduate course basics with gradually reducing the Guanosine Diphosphate dose basics of 100 mg. 3 g / day) treatment duration is 4 weeks to 1.5 - 3 months at uroporfiriyi Inosine appoint 0.8 g / day (Table 1. Side effects and complications in the use of drugs: when to and in the introduction, especially jet, you may experience dryness and metallic taste in the Quart basics of heat throughout the body, odor, scratching in the throat and chest discomfort cage, shortness of breath; these phenomena associated with excessive speed the drug and are intermittent in nature.